Welcome to Cell2TherapyTM. We are a Contract Translational service provided by Intercytex Ltd for the Cell Therapy industry. Cell2TherapyTM has been set up following interest in Intercytex’s capabilities from academics, clinicians and Companies in Europe and the U.S. The goal of Cell2TherapyTM is to help clients in any of the steps they need to bring their Autologous or Allogeneic Cell Therapies through the clinic and beyond, either as a contract service or by training and mentoring their scientists and staff. We support ALL aspects of the process; from development of Clinical Approvals, through GMP manufacture of cells as IMPs for clinical study or under ‘Specials’. We also provide mentoring and training for client’s staff right through to running the trials themselves, as well as running clinical trials themselves through our network of CRAs.
We understand that every project is unique and we can tailor a package to help you translate your Cell Therapy into use.